INVESTMENTS
Biotech firm Kailos Genetics gets backing from IC venture arm In-Q-Tel
- By Ross Wilkers
- Jul 12, 2017
Biotechnology firm Kailos Genetics has received an investment from the intelligence community investment arm In-Q-Tel to help further develop a new genetic sequencing laboratory.
Terms of the partnership were not disclosed. IQT seeks to further spur efforts on both the laboratory and cloud-based software used to perform genetic sequencing.
Huntsville, Ala.-based Kailos started in 2010 to advance genetic testing for partners such as hospitals, physicians, laboratories and pharmacies. Kailos' portfolio includes a laboratory information system built to manage samples in a lab environment, perform analytics and give users reports.
Founded in 1999, IQT seeks to identify startup companies whose technologies have potential use in the intelligence community.
About the Author
Ross Wilkers is a senior staff writer for Washington Technology. He can be reached at rwilkers@washingtontechnology.com. Follow him on Twitter: @rosswilkers. Also connect with him on LinkedIn.